{
  "compound": "CBD",
  "condition": "ARTHRITIS",
  "effect_size": "Large (Cohen's d = 0.91)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:ARTHRITIS_OBSERVATIONAL_002",
  "participants": "247 psoriatic arthritis patients using CBD",
  "year": 2020,
  "notes": "Cannabidiol for Psoriatic Arthritis: Canadian Registry Analysis",
  "confidence": "medium",
  "abstract": "58% achieved DAPSA response (reduction \u226550%); mean score 32.1 \u2192 16.4 (49% reduction)"
}